At a time when the Covid-19 epidemic is marking a new resurgence in France, health authorities are recommending extending the age limit of the population eligible for a booster dose to 40 and over, according to a press release issued today.
The Higher Health Authority (HAS) also recommends that the booster dose be given six months after the start of the initial vaccination, with “recent studies actually showing that there is a benefit to this age range”.
In France, only those over 65 years of age and those at risk of serious illness should receive a booster dose to counteract the declining effectiveness of vaccines over time. From December 15, this will be necessary for the extension of their health pass.
From December 1, this booster dose will be available to 50-64 year olds.
For other ages, this dose is not yet on the agenda.
“I would not be surprised if we gradually went to the commemorative doses of vaccines for all adults who have been vaccinated, this is the course of history,” French President Emmanuel Macron said today, on the sidelines of a visit to northern France.
The French High Authority for Health explains its new recommendation based on data that “supports the benefits of a booster dose”.
It is based on the example of Israel where this dose “contributes to excellent levels of protection against SARS-CoV-2 infection, including in people under 60 years of age”.
“There is a reduction in the risk of infections, severe forms, illness and death in people aged 40 and over who have taken a booster dose compared to those who did not.”
SOURCE:
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
